Most Common Immunological and Autoimmune Disorders
Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Major Pharma Companies
recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo
AstraZeneca’s Ultomiris; HebaBi...

AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy ...

pharma-news-and-updates-for-nanox-takeda-visus-lqt-therapeutics
LQTT secures $19M; Nanox acquires Zeb...

LQT Therapeutics secures USD 19 Million to tackle heart diseases with Sanofi compounds LQT Therapeutics int...

peanut-allergy-market-size-share-trends-prevalence-therapies-therapeutics-drugs
Peanut Allergy Market Outlook: The Ma...

Peanut allergy (PA) is one of the most common food allergies that affect children in Western nations. It is...

leading-companies-in-autoimmune-diseases-market
Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Major Pharma Companies

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million people in the USA are affected by autoimmune diseases such as rheumatoid arthritis, psoriasis, and lupus. The...


latest-biotech-healthcare-pharma-news-updates-aelis-farma-alcyone-progentec-gsk-kozin
Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collabor...

Aelis Farma pockets USD 30 Million upfront in cannabis use disorder deal with IndiviorIndivior speculates that Aelis Farma has what it takes to bring cannabis use disorder therapy into the cli...


adult-onset-stills-disease-treatment-market
Essential Demands Impinge the Evolving Adult-onset Still’s Disease Treatment Market

Adult-onset Still’s Disease (AoSD), alternatively known as systemic-onset juvenile idiopathic arthritis, is a rare systemic inflammatory disorder of unknown etiology. There are three main patterns...


Antibody mediated Rejection Market
Is Antibody-mediated Rejection a Roadblock to Organ Transplantation?

Over the last decades, organ transplantation has become the leading treatment option for patients with last-stage organ failure. However, although it has significantly reduced the mortality rate, ...


recent-pharma-happenings-for-eli-lilly-mina-appia-bio-nuvalent
Lilly ink deal with MiNA; Appia Bio aims for CAR-T with $52M raise; Nuvalent raises $135M; Orchar...

Lilly, MiNA ink agreement to upregulate proteins using RNAEli Lilly will utilise the power of MiNA Therapeutics’ proprietary small activating RNA (saRNA) technology platform to develop five no...


recent-pharma-biotech-news-updates-happenings-for-abbott-biogen-eli-lilly-arch-oncology
Arch Oncology scores $105M; Abbott’s new coronary imaging platform; Lilly scraps IL-23 psoriasis ...

Arch Oncology scores USD 105 Million for anti-CD47 med in solid tumors, multiple myelomaArch Oncology scored USD 105 million from new and old backers to expand the drug’s journey through the c...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...

Leading Autoimmune Diseases to Undergo Robust Improvement in Treatment by Maj...

As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...